http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105879062-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-1851
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0002
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-18
filingDate 2016-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2019-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105879062-B
titleOfInvention Three mode targeted contrast agent of lung non-small cell carcinoma optics and its preparation method and application
abstract The present invention relates to one kind based on three mode targeted contrast agent of lung non-small cell carcinoma CT/MR/ near-infrared optical and its preparation method and application, and preparation method includes: that the amino terminal of the 5th polyamide-amine dendrimer is modified with DOTA-NHS;Folid acid is then connected to by dendrimer by polyethylene glycol;Then further modified with Cy5.5;Using the dendrimer after modifying as template, gold nano grain is prepared by sodium borohydride reduction, gadolinium ion is sequestered in macromolecular later;Whole acetylation process finally are carried out to the amino of dendrimer surface residual;Solution after reaction is dialysed, freeze-drying process obtains finished product;External, internal three mode radiography performance of CT/MR/ near-infrared optical is carried out to product to evaluate.The method of the present invention is simple and easy, has the inside and outside lung non-small cell carcinoma cell-targeting effect of good body, has potential targeting CT/MR/ near-infrared optical radiography application prospect.
priorityDate 2016-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449434161
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159739
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10090
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID102103
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454306093
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID482532689
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10090
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451404211
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22959485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4311764
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453277883
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28133
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419496680
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25014653
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512034
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7918

Total number of triples: 41.